Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications.
about
Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in JapanClinical and biochemical manifestations of depression: relation to the neurobiology of stressAntidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription - a possible mechanismPronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone.Regulation of corticosteroid receptor gene expression in depression and antidepressant actionThe combined dexamethasone/CRH Test (DEX/CRH test) and prediction of acute treatment response in major depressionNPY1 Receptor Agonist Modulates Development of Depressive-Like Behavior and Gene Expression in Hypothalamus in SPS Rodent PTSD Model.Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behaviorEffects of adrenal cortex hormones on limbic structures: some experimental and clinical correlations related to depression.Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus.Repeated electroconvulsive shock produces long-lasting increases in messenger RNA expression of corticotropin-releasing hormone and tyrosine hydroxylase in rat brain. Therapeutic implicationsAbnormalities of cAMP signaling in affective disorders: implication for pathophysiology and treatment.Effect of chronic administration of selective glucocorticoid receptor antagonists on the rat hypothalamic-pituitary-adrenocortical axis.Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans.The impact of corticosteroids on the developing animal.Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone.Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states.The role of CREB and other transcription factors in the pharmacotherapy and etiology of depression.Neuropeptides and the hypothalamic-pituitary-adrenocortical (HPA) system: review of recent research strategies in depression.Effects of Hypericum perforatum extract on rat irritable bowel syndrome.Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depressionReduced vasopressin receptors activation mediates the anti-depressant effects of fluoxetine and venlafaxine in bulbectomy model of depression.Chronic stress, depression and antidepressants: effects on gene transcription in the hippocampus.Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions.Chronic P-glycoprotein inhibition increases the brain concentration of escitalopram: potential implications for treating depressionAre compounds acting at metabotropic glutamate receptors the answer to treating depression?Candidate genes for antidepressant response to selective serotonin reuptake inhibitorsNobiletin Ameliorates the Deficits in Hippocampal BDNF, TrkB, and Synapsin I Induced by Chronic Unpredictable Mild StressThe mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression.Mineralocorticoid receptor overexpression facilitates differentiation and promotes survival of embryonic stem cell-derived neurons.Saliva estriol levels in women with and without prenatal antidepressant treatment.Glucocorticoid status affects antidepressant regulation of locus coeruleus tyrosine hydroxylase and dorsal raphé tryptophan hydroxylase gene expression.A mixed glucocorticoid/mineralocorticoid receptor modulator dampens endocrine and hippocampal stress responsivity in male rats.Research on potential biomarker correlates for suicidal behavior: A review.Regulation of the human corticotropin-releasing-hormone gene promoter activity by antidepressant drugs in Neuro-2A and AtT-20 cells.Differential effects of antidepressants on glucocorticoid receptors in human primary blood cells and human monocytic U-937 cells.Corticosteroid resistance and disease.Increased mRNA for corticotrophin releasing hormone in the amygdala of fawn-hooded rats: a potential animal model of anxiety.St John's wort and imipramine-induced gene expression profiles identify cellular functions relevant to antidepressant action and novel pharmacogenetic candidates for the phenotype of antidepressant treatment response.St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
P2860
Q24658320-0497F24F-6EF4-4D21-85CE-0947C72BF556Q26824899-08A2D526-01DB-4E35-8478-6E7925D3D35BQ28344504-88CA217B-B028-4066-9C1D-D2F51E3E703BQ30454280-C646A223-64A3-4651-A56E-EA8A7F3C12D1Q30498987-EE1F768B-0A5F-42CA-BF4D-73B417114A28Q33403748-544F01DE-F4AA-461C-A625-3A24F4D7E254Q33575917-F6A2942D-7CBA-4409-B61E-5C6BD17F0F52Q33722443-C56A71C9-D981-434D-98F0-F896C176CF9BQ33921155-7527C337-DBB3-41C5-BE4E-3267CFE4E87BQ33926970-28D04401-7334-4703-81CD-17D7237CD0FCQ34185892-EDFB6A2E-7AF4-4AC5-97CC-80BE74E93969Q34186921-2EDF8C18-DC04-4DCE-81E4-F782C94DFAE2Q34191282-45C8E6BC-86A6-4FFA-95C1-7655276A2099Q34348095-D07849EE-6D84-4CF0-925C-1409258951EEQ34377634-4161E999-6556-4A95-B514-F7751D01A653Q34514099-B2D9BB06-83E9-4CE2-BDB2-0AC93FDB0012Q34580335-6770FB37-37CC-4DFB-8DEC-EEAE861490A5Q35009342-E91BC088-F38A-4B99-94EC-0079D1D4C155Q35073814-018AEF27-A77C-49DE-A447-044E37476103Q35215213-1A460A3E-F3CC-4250-9898-F8C6C0F637A3Q35790395-2DFB09AB-7F63-4E37-939E-97DA46019BD7Q35877541-27A70EE9-E4AD-40E2-8FBD-4F6C89B5B797Q36089265-771CF88D-C5E6-42C3-8213-4EDD723E1CF6Q36553056-DC5FC8D7-BA12-459B-AF1B-97C4B02EA7EBQ36648861-8D514617-D808-4A85-A95C-DE4348F7218EQ36654331-EB19C366-661D-478E-A1BF-8857975932F2Q36718053-42D96E15-2747-4F30-9CC6-86A4D149DAA7Q36731158-6418F5E2-354B-4292-94DF-7CF48DB19130Q36787614-8B52FE54-186B-4368-ABD2-62D0E9B6E29CQ36804573-55F3B446-9F98-46A4-9341-86F5A1113F59Q36924142-0E17693C-5D2E-4F01-B6B9-3905865309B7Q37369470-F2FBE701-D760-4911-8E5A-C240DE1C8F01Q39017834-DC14F157-3363-4064-BE66-0032E828A706Q39388038-702383B2-9D00-4C70-98F3-5842DF5CFE97Q40597197-62E2BF86-84F8-4AE9-BECA-14B74DC82694Q40661639-9976433C-AF73-4BDB-97D2-D4830A7B44A3Q41387041-B924D8AB-89DA-409F-B611-9A28E0CA8698Q42438721-7F5B77C7-3F4F-4E11-9BF9-B311105B7AB1Q42618139-245911CE-B2EB-4997-8B36-6ABA0EFFE6F9Q42658073-4AA94377-DA39-4910-B962-A715F2A20957
P2860
Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Long-term antidepressant admin ...... ain. Therapeutic implications.
@ast
Long-term antidepressant admin ...... ain. Therapeutic implications.
@en
type
label
Long-term antidepressant admin ...... ain. Therapeutic implications.
@ast
Long-term antidepressant admin ...... ain. Therapeutic implications.
@en
prefLabel
Long-term antidepressant admin ...... ain. Therapeutic implications.
@ast
Long-term antidepressant admin ...... ain. Therapeutic implications.
@en
P2093
P2860
P356
P1476
Long-term antidepressant admin ...... ain. Therapeutic implications.
@en
P2093
P2860
P304
P356
10.1172/JCI115086
P407
P577
1991-03-01T00:00:00Z